ANDOVER, Mass., November 22, 2025--(BUSINESS WIRE)--Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and ...
ANDOVER, Mass., Feb. 23, 2023 /PRNewswire/ -- Transmural Systems the leader in transcatheter electrosurgery for structural interventions announced today successful first-in-human procedure with its ...
Please provide your email address to receive an email when new articles are posted on . Endologix announced that the FDA has granted approval of its percutaneous transmural arterial bypass system for ...
Hosted on MSN
FDA greenlights Transmural Systems’ TAVR guidewire
The US Food and Drug Administration (FDA) has approved Transmural Systems’ Telltale, a dedicated electrosurgical guide wire to reduce the risk of coronary obstruction in high-risk patients undergoing ...
IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, ...
Endologix LLC reported 12-month results from the second of two studies of a fully percutaneous, transmural arterial bypass therapy for treating peripheral arterial disease. Presented at this month's ...
Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for TELLTALE – the first and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback